Shenzhen Lifotronic Technology Co., Ltd. (688389.SS)
CNY 15.22
(0.33%)
CNY 15.22
(0.33%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 328.57 Million CNY | 30.66% |
| 2022 | 251.48 Million CNY | 32.12% |
| 2021 | 190.34 Million CNY | 32.23% |
| 2020 | 143.94 Million CNY | 43.15% |
| 2019 | 100.55 Million CNY | 23.93% |
| 2018 | 81.14 Million CNY | 70.52% |
| 2017 | 47.58 Million CNY | 381.67% |
| 2016 | 9.87 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 64.65 Million CNY | -39.69% |
| 2024 Q3 | 85.53 Million CNY | 32.29% |
| 2024 Q1 | 107.21 Million CNY | -13.3% |
| 2023 Q3 | 70.39 Million CNY | 51.69% |
| 2023 Q1 | 88.1 Million CNY | -10.49% |
| 2023 FY | 328.57 Million CNY | 30.66% |
| 2023 Q4 | 123.66 Million CNY | 75.67% |
| 2023 Q2 | 46.4 Million CNY | -47.33% |
| 2022 Q3 | 53.56 Million CNY | 65.55% |
| 2022 Q2 | 32.35 Million CNY | -51.81% |
| 2022 Q1 | 67.14 Million CNY | -1.41% |
| 2022 FY | 251.48 Million CNY | 32.12% |
| 2022 Q4 | 98.42 Million CNY | 83.75% |
| 2021 Q3 | 39.81 Million CNY | 40.03% |
| 2021 FY | 190.34 Million CNY | 32.23% |
| 2021 Q4 | 68.1 Million CNY | 71.05% |
| 2021 Q2 | 28.43 Million CNY | -47.34% |
| 2021 Q1 | 53.99 Million CNY | 5.79% |
| 2020 Q4 | 51.03 Million CNY | 118.66% |
| 2020 Q3 | 23.34 Million CNY | -26.81% |
| 2020 Q1 | 37.68 Million CNY | 9.36% |
| 2020 FY | 143.94 Million CNY | 43.15% |
| 2020 Q2 | 31.88 Million CNY | -15.38% |
| 2019 Q2 | 23.28 Million CNY | -15.07% |
| 2019 FY | 100.55 Million CNY | 23.93% |
| 2019 Q4 | 34.45 Million CNY | 123.87% |
| 2019 Q3 | 15.39 Million CNY | -33.91% |
| 2019 Q1 | 27.42 Million CNY | -24.44% |
| 2018 Q4 | 36.28 Million CNY | 0.0% |
| 2018 FY | 81.14 Million CNY | 70.52% |
| 2017 FY | 47.58 Million CNY | 381.67% |
| 2016 FY | 9.87 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Chison Medical Technologies Co., Ltd. | 146.48 Million CNY | -124.316% |